Submissions

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
The submission file is in Microsoft Word format.
Where available, DOIs for the references have been provided.
Ethical approval has been specified where applicable.
The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines. The text is single-spaced; uses a 12-point font; main headings in capital letters (JOURNAL OF CONTEMPORARY PHARMACY), subheadings starting with first capital letter (Journal of Contemporary Pharmacy); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.

Author Guidelines

MANUSCRIPT SUBMISSION

Type-written manuscripts prepared using Microsoft Word should be submitted preferably through Make a submission. Articles may also be submitted to editor.jcp@ammanif.com along with a covering letter by the corresponding author.

MANUSCRIPTS PREPARATIONS

General Format	Language: English Font style: Times New Roman Font size: 12 Margins: 1 inch on paper size A4 Line spacing: double Words Limit: Review articles- 4500 words abstract through conclusion Original Research- 3000 words Brief Reports/ Short communications -1500 words Main headings should be in uppercase only, 12 font size, times new roman, bold. Sub-headings should be in lowercase only, 12 font size, times new roman, bold.
Title page	A title page should contain 1. Concise and descriptive title of the manuscript. in uppercase only, 12 font size, times new roman, bold. 2. The name(s) and affiliation(s) of the author(s). If co-author(s) are from different organizations, their address (es) too should be mentioned and numbered using superscripted digit after their names. 3. The mailing address, telephone and e-mail address of the corresponding author.
Abstract	Each manuscript should contain an abstract of up to 250 words in a structured form, consisting of: Objective, Methods, Results, and Conclusion. Please include 3-5 keywords.
Introduction	It should contain a concise research background and states in separate paragraph the objective(s) of the study.
Materials and methods	All important materials used along with their source shall be mentioned. The statistical method and the level of significance chosen shall be clearly stated. All the ethical permission associated in the research work must be specified.
Results	This part should reveal the findings of own works.
Discussion	It requires the interpretation of the results. No need to repeat the results. There should be logical reasoning and scientific proof with comparison and references those of other studies.
Conclusion	Conclude the outcomes in the light of aims of the study.
Tables	The concise title of the table (s) should clearly indicate the contents nature and should be cited in the text.
Figures	The concise title of the figure (s) should clearly reflect the graphics and should be cited in the text.
Acknowledgements	All acknowledgments should be typed in one paragraph directly preceding the reference section.
References	Reference in Text: References should be numbered consecutively in the order in which they are first mentioned in the text. Cite references in manuscript text by Arabic numerals in square brackets and bold. Reference in List: Journals: Author(s). Title of Article. Journal name. Volume (Issue), Page numbers, Year. For Example: Naeem MA, Mahmood A. Production and stability evaluation of modified-release microparticles for the delivery of drug combinations. AAPS PharmSciTech. 11(1), 351-55, 2010. Books: Author (s). Title of Book. Ed, Publisher, Country, Page numbers, Year. For Example: Raymond CR, Paul JS, Marian EQ. Handbook of Pharmaceutical Excipients. Sixth edition, Pharmaceutical Press London, United Kingdom, p. 233-234, 2009.

Articles

Section default policy

New Section

Here is the section Policy.Here is the section Policy.Here is the section Policy.Here is the section Policy.Here is the section Policy.

Copyright Notice

Require authors to agree to the following copyright notice as part of the submission process.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.